CN112807391A - Intelligence-promoting traditional Chinese medicine composition - Google Patents
Intelligence-promoting traditional Chinese medicine composition Download PDFInfo
- Publication number
- CN112807391A CN112807391A CN202110207108.8A CN202110207108A CN112807391A CN 112807391 A CN112807391 A CN 112807391A CN 202110207108 A CN202110207108 A CN 202110207108A CN 112807391 A CN112807391 A CN 112807391A
- Authority
- CN
- China
- Prior art keywords
- parts
- intelligence
- traditional chinese
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides an intelligence-developing traditional Chinese medicine composition which comprises the following components in parts by mass: 15 parts of astragalus membranaceus, 10 parts of Tibetan angelica, 10 parts of rhizoma pinellinae praeparata, 10 parts of bamboo shavings, 6 parts of immature bitter orange, 5 parts of saffron crocus, 10 parts of zang ganoderma lucidum, 10 parts of polygala tenuifolia, 10 parts of dried orange peel, 10 parts of poria cocos and 6 parts of liquorice; the invention has simple preparation and low price, can effectively benefit intelligence, tranquilize mind, tonify kidney, strengthen brain, dredge meridian passage, regulate qi and blood, and is effectively suitable for cerebral palsy, hemiplegia, paraplegia, hemiplegia, epilepsy and neurological disorder diseases.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for improving intelligence.
Background
Hemiplegia is a popular name of stroke, and is commonly called hemiplegia due to the fact that stroke patients mostly become hemilateral physical immobility, so that the hemiplegia is called hemiplegia visually in traditional Chinese medicine, and cerebrovascular disease and stroke are called western medicines.
Due to cerebrovascular disease, lesion in brain tissue, intracranial nerve cell damage, and motor nerve cell push control of cranial nerve motor nucleus and spinal cord gray matter cause corresponding part of physical paralysis. Hemiplegia is clinically manifested by facial distortion, dyskinesia of one side of the upper and lower limbs, facial muscles and lower parts of tongue muscles, and slurred speech.
Paraplegia, a kind of paralysis, belongs to a disease of loss or reduction of function of part or all of the trunk of two lower limbs corresponding to nerve injury caused by spinal cord injury caused by various reasons.
At present, hemiplegia and paraplegia are one of the difficult and complicated diseases in human medicine, and although some auxiliary treatment measures, such as carotid artery pressurization drug injection therapy, have the defects of long treatment course, slow effect, high price, inconvenient use and the like.
Disclosure of Invention
The invention aims to solve the technical problems and provides an intelligence-improving traditional Chinese medicine composition which is simple to prepare and low in price, can effectively improve intelligence and tranquilize, tonify kidney and strengthen brain, dredge meridian passage and harmonize qi and blood, and is effectively suitable for cerebral palsy, hemiplegia, paraplegia, hemiplegia, epilepsy and neurological disorder diseases.
In order to achieve the technical purpose, the technical scheme adopted by the invention is as follows: the intelligence-benefiting traditional Chinese medicine composition comprises the following components in parts by weight: 15 parts of astragalus membranaceus, 10 parts of Tibetan angelica, 10 parts of rhizoma pinellinae praeparata, 10 parts of bamboo shavings, 6 parts of immature bitter orange, 5 parts of saffron crocus, 10 parts of zang ganoderma lucidum, 10 parts of polygala tenuifolia, 10 parts of pericarpium citri reticulatae, 10 parts of poria cocos and 6 parts of liquorice.
The invention has the beneficial effects that:
1. the traditional Chinese medicine composition has the advantages of low raw material price, convenient preparation, good absorption effect, long drug effect duration, no toxic or side effect and high safety, and is beneficial to timely alleviating symptoms of patients;
2. the astragalus and saffron are added as monarch drugs in the invention, and the astragalus is sweet and warm and enters spleen, strengthens spleen and tonifies qi, enters lung channels of spleen and stomach, and can tonify deficiency and nourish five internal organs; the invention discloses a traditional Chinese medicine preparation for treating phlegm-resolving and refreshing, which is prepared from rhizoma pinellinae praeparata, caulis bambusae in taeniam and fructus aurantii immaturus. Treating amenorrhea, abdominal mass, dystocia, dead fetus, postpartum lochiorrhea, pain caused by blood stasis, carbuncle and swelling, traumatic injury;
3. the polygala root is added in the invention, so that the nerve can be effectively calmed and intelligence can be effectively improved;
4. according to the invention, the dried orange peel and the tuckahoe are adopted as adjuvant medicines, the dried orange peel promotes qi of lung and spleen to smooth chest and diaphragm, and the tuckahoe supplements middle-jiao and benefits qi, strengthens spleen and excretes dampness, so that phlegm can be effectively reduced and spleen can be strengthened;
5. the liquorice is added as a messenger drug, so that the traditional Chinese medicine can effectively tonify qi, invigorate spleen and harmonize the medicines;
6. the invention adopts the multipurpose important formula with good efficacy on improving intelligence and calming nerves, tonifying kidney and strengthening brain, clearing and activating the channels and collaterals and regulating qi and blood, and has reasonable proportion, can effectively reach the focus directly, achieves the effects of clearing and activating the channels and collaterals and regulating qi and blood, and further can effectively cure the neurological disorder diseases.
Detailed Description
The invention is further illustrated below with reference to specific examples.
The intelligence-benefiting traditional Chinese medicine composition comprises the following components in parts by weight: 15 parts of astragalus membranaceus, 10 parts of Tibetan angelica, 10 parts of rhizoma pinellinae praeparata, 10 parts of bamboo shavings, 6 parts of immature bitter orange, 5 parts of saffron crocus, 10 parts of zang ganoderma lucidum, 10 parts of polygala tenuifolia, 10 parts of pericarpium citri reticulatae, 10 parts of poria cocos and 6 parts of liquorice.
In order to further examine the clinical efficacy and safety of the medicine, 1326 cases of patients with hemiplegia and paraplegia are clinically observed and treated from 2005 to date.
The treatment method comprises the following steps:
the medicine is orally taken after meals by 10g twice a day, the treatment time is calculated according to the condition of patients, patients with mild diseases are cured after taking the medicine for 10-15 days, and patients with severe diseases are cured after taking the medicine for 60-90 days.
Criteria for therapeutic effect
The standard of curative effect refers to the national standard of "conventional diagnosis and treatment of internal diseases of traditional Chinese medicine".
Examination item
Checking the upper and lower limbs, the body muscles, the facial paralysis and the like of the patient and the comprehensive recovery condition, and grading the neurological impairment degree: three routine and blood fat and blood rheology examinations
Basically curing: the functional impairment score is reduced by 91-100%, and the disease disability degree is grade 0;
the effect is shown: the functional impairment score is reduced by 46-90%, and the disease disability degree is grade 1-3;
the method has the following advantages: the functional impairment score is reduced by 18-45%;
and (4) invalidation: functional impairment score decreased by less than 17%.
Clinical results
1046 cases (78.88%) of basic cure, 151 cases (11.38%) of obvious effect, 101 cases (7.61%) of effective effect, 28 cases (2.11%) of ineffective effect and 97.87% of total effective rate.
Typical cases
Case 1: wangli, women, age 61, suffered from cerebral hemorrhage by falling, and then left paralysis, which was restored to walking by the state of delirium according to the treatment method of the application, and basically restored to work.
Case 2: bouffa, female, age 57, suddenly stunned and coma, and was diagnosed as cerebral thrombosis, which failed to work and live normally. After one month of use, the symptoms disappear and the activity is free. After one month, CT pictures show that all the components are normal and the patients are cured.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single technical solution, and such description of the present description is for clarity only, and those skilled in the art should make the description as a whole, and the technical solutions in the embodiments may be appropriately combined to form other embodiments understood by those skilled in the art.
Claims (1)
1. A traditional Chinese medicine composition for improving intelligence is characterized in that: the composition comprises the following components in parts by mass: 15 parts of astragalus membranaceus, 10 parts of Tibetan angelica, 10 parts of rhizoma pinellinae praeparata, 10 parts of bamboo shavings, 6 parts of immature bitter orange, 5 parts of saffron crocus, 10 parts of zang ganoderma lucidum, 10 parts of polygala tenuifolia, 10 parts of pericarpium citri reticulatae, 10 parts of poria cocos and 6 parts of liquorice.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110207108.8A CN112807391A (en) | 2021-02-24 | 2021-02-24 | Intelligence-promoting traditional Chinese medicine composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110207108.8A CN112807391A (en) | 2021-02-24 | 2021-02-24 | Intelligence-promoting traditional Chinese medicine composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112807391A true CN112807391A (en) | 2021-05-18 |
Family
ID=75865375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110207108.8A Pending CN112807391A (en) | 2021-02-24 | 2021-02-24 | Intelligence-promoting traditional Chinese medicine composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112807391A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007225456A1 (en) * | 2006-03-16 | 2007-09-20 | Moleac Pte Ltd | Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
CN103202964A (en) * | 2013-04-23 | 2013-07-17 | 山东上水农业发展股份有限公司 | Brain-improving and mind-calming medicinal liquor |
-
2021
- 2021-02-24 CN CN202110207108.8A patent/CN112807391A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007225456A1 (en) * | 2006-03-16 | 2007-09-20 | Moleac Pte Ltd | Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
CN103202964A (en) * | 2013-04-23 | 2013-07-17 | 山东上水农业发展股份有限公司 | Brain-improving and mind-calming medicinal liquor |
Non-Patent Citations (1)
Title |
---|
张勇: "温胆汤加味治疗缺血性脑中风80例", 《河南中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103251814B (en) | The Chinese medicine preparation of a kind of adjusting hypertension, hyperlipidemia, hyperglycemia | |
US20210169779A1 (en) | Ophthalmic drug preparation and uses thereof | |
CN105663607A (en) | Traditional Chinese medicine composition as well as preparation method and application thereof | |
CN105106440B (en) | A kind of Chinese medicine composition for the treatment of headache and dizzy after lumbar anesthesia | |
CN102670803A (en) | External used Chinese plaster applied onto navel for curing infantile diarrhea | |
CN100546625C (en) | A kind of Chinese medicine composition for the treatment of the endocrine disturbance | |
CN112807391A (en) | Intelligence-promoting traditional Chinese medicine composition | |
CN112741890B (en) | Traditional Chinese medicine composition for treating vertigo and preparation method thereof | |
CN102000238A (en) | Martianus dermestoides capsule and preparation method | |
CN114869949A (en) | A pharmaceutical composition for treating puerperal diseases, and its preparation method | |
CN103990009A (en) | Traditional Chinese medicine for treatment of type II diabetes by invigorating spleen and purging turbidness | |
WO2022147925A1 (en) | Patch for treating male erectile dysfunction and preparation method therefor | |
CN107812135B (en) | Composition for preventing and treating sexual precocity of children | |
CN102309686A (en) | Medicinal composition for rehabilitation and application thereof | |
CN112076297A (en) | Pharmaceutical composition for preventing miscarriage and stopping vomiting and preparation method and application thereof | |
CN101199761B (en) | Drug for treating arteriosclerosis | |
CN105233167A (en) | Medicine composition for treating vascular neuralgia headache | |
CN105381388A (en) | Traditional Chinese medicine composition for treating stomach discomfort and preparing method thereof | |
CN104800491A (en) | Oral solution with superstrong function of improving human immunity | |
CN110292622A (en) | A kind of Chinese medicine composition and preparation method thereof for treating meningioma | |
CN115192684B (en) | A Chinese medicinal composition for relieving or treating pain, and its preparation method | |
CN108686178B (en) | Traditional Chinese medicine acupoint emplastrum for treating Parkinson's disease and preparation method thereof | |
CN107753839B (en) | Traditional Chinese medicine composition, application thereof, traditional Chinese medicine plaster containing traditional Chinese medicine composition, and preparation and application methods thereof | |
CN107115483B (en) | Pharmaceutical composition for treating muscular dystrophy and myasthenia and application thereof | |
CN101108210A (en) | Medicine for treating cervical vertebra disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210518 |
|
RJ01 | Rejection of invention patent application after publication |